ROCKVILLE, Maryland, April 17, 2018 -- For years, if not decades, some very profitable business groups and health insurance providers have tried and pursued a discrimination strategy against ESRD patients. It’s appalling.
|
|||
The real steering playbook is outlined in today’s letter spearheaded by insurers, employers and labor unions: let’s get these people off employer-provided insurance and let’s push them onto the government rolls whether that works for them or not.
Unfortunately, many times, only when people have a personal experience (family or friend) with ESRD do they realize the difficult health care decisions patients have to make. To the powerful groups that spearheaded this letter, ESRD patients are a cost that they want shifted elsewhere. To us, they are men, women, husbands, wives, mothers and fathers who deserve the dignity to have the health care that best suits their personal and family situation, even if they need charitable help to pay for it.
Our goal is to make health coverage possible for those who can least afford it when they get kidney disease. With very few exceptions, these are patients with little to no meaningful assets. Certainly not enough to afford health care without tremendous out-of-pocket costs. We help patients with any type of insurance plan they’ve chosen, public or private. It’s ironic that the same insurers who say all ESRD patients belong on Medicare are, at the same time, denying charitable premium assistance that allows Medicare patients to afford the Medigap plans that protect them from personal financial ruin.
These groups don’t understand what these patients experience. They just look at cost and say it should be someone else’s problem to bear.
Health care coverage cannot just be for healthy people. This letter should send a chill down the spine of every person with a chronic disease. Which disease will be rejected by insurers and employers for health coverage next--cancer, diabetes, obesity or asthma? Because they won’t just stop with kidney failure.
This outright discrimination against ESRD patients, who are disproportionately members of minority groups, has to stop. It’s a life and death situation, and like previous Administrations, Congresses and courts, we believe Secretary Azar will reject this cynical effort to deny health coverage to people who need it most.
NOTE: The American Kidney Fund submitted a letter to Health & Human Services Secretary Azar today correcting false assertions in the letter from the insurance industry. The full text of the letter is available at http://www.kidneyfund.org/assets/pdf/advocacy/akf-letter-to-secretary-azar.pdf .
Alice Andors American Kidney Fund 240-292-7053 [email protected]


Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
Same sparkle, different story: how lab-grown diamonds are transforming the market
World game at war: why some European nations have threatened a World Cup boycott
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Capital One Says AML Review Led to Closure of Trump Organization Accounts
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
Japan Earthquake Disrupts Auto and Chip Supply Chains
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation 



